TickerFacts.

Aspire-Lakewood Holdings, Inc. (ASBP): Total Liabilities

Annual figures by period end, from SEC filings.

$7.69M
As of 2025-12-31
$1.78M
As of 2026-06-30
-11.6%
3-year compound annual growth
$11.12M2021-12-31: $293.7K2022-12-31: $11.12M2023-12-31: $403.3K2024-12-31: $1.69M2025-12-31: $7.69M$7.69M
2021-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$7.69M+355.5%2026-04-08, Balance as of period end
2024-12-31$1.69M+318.5%2026-04-08, Balance as of period end
2023-12-31$403.3K-96.4%2025-04-07, Balance as of period end
2022-12-31$11.12Mn/m2024-03-11, Balance as of period end
2021-12-31$293.7Kn/a2023-03-21, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Aspire-Lakewood Holdings, Inc. (ASBP)2025-12-31$7.69M+355.5%
Alaunos Therapeutics, Inc. (TCRT)2025-12-31$813.0K+17.5%
One World Products, Inc. (OWPC)2024-12-31$5.26M+35.7%
Genelux Corp (GNLX)2025-12-31$7.48M-11.4%
Aditxt, Inc. (ADTX)2025-12-31$12.56M-47.3%
PRF Technologies Ltd. (PRFX)2025-12-31$2.71M+0.3%
Bioadaptives, Inc. (BDPT)2025-12-31$2.36M+36.5%
Skinvisible, Inc. (SKVI)2025-12-31$10.39M+10.8%
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$7.40M+264.3%

Compare ASBP, TCRT, OWPC, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗